The Oncology Institute: Making Progress
The Oncology InstituteThe Oncology Institute(US:TOI) Seeking Alpha·2025-12-18 20:48

Core Insights - The Oncology Institute, Inc. (TOI) has shown signs of imminent profitability, with a notable 37% improvement reported in its 3Q25 results, leading to a rally in its shares since November 14, 2025 [2]. Company Summary - TOI specializes in cancer care and cost management solutions, indicating a focus on addressing both treatment and financial aspects of cancer care [2]. - The company is part of a model portfolio that includes 12-20 high upside biotech stocks, suggesting a strategic approach to investment in the biotech sector [2].